
|Videos|December 9, 2021
Virtual genetics board to discuss high-risk localized prostate cancer, BRCA1-related management
Author(s)Urology Times staff
“We will also cover options for germline testing—different ways that tests can be ordered, panel options that are available commercially,” says Veda N. Giri, MD.
Advertisement
In this video, Veda N. Giri, MD, offers a preview of the ENGAGEMENT Study Virtual Genetics Board’s upcoming case discussion, which you can sign up for by going to
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study launches of MRI plus PSMA-PET imaging for prostate cancer detection
2
CREST and POTOMAC: Redefining immunotherapy’s role in NMIBC
3
Initial ARID results published in World Journal of Urology as pivotal trial progresses
4
New Data Influencing your Treatment Decisions in mCSPC
5



















